Kenya calls for stronger global drug control measures at UN meeting in Vienna

Speaking at the 68th Commission on Narcotic Drugs (CND) in Vienna, Austria, Dido Raso, Member of Parliament for Saku and part of Kenya’s delegation, emphasized the country’s commitment to addressing the evolving challenges of substance abuse.

Representing Kenya, Raso highlighted the urgent need for global cooperation in tackling the rising misuse of specific drugs and urged further evaluation of substances that pose significant public health risks.

“Kenya appreciates and honors the treaty-mandated role of the World Health Organization (WHO) and the International Narcotics Control Board (INCB) in researching and assessing substances and their impact on human health,” said Raso.

He reaffirmed Kenya’s support for the recommendations outlined in recent WHO and INCB reports, particularly those concerning substances with harmful health effects.

“Upon review of the report and in light of their adverse effects, Kenya supports the recommendations and commits to being on alert for all substances categorized for surveillance,” he stated.

Raso raised concerns over the increasing misuse of certain pharmaceuticals, including Tramadol and Ketamine, which have become prevalent in Kenya and other regions.

“While I have the floor, I urge the WHO once again to undertake further evaluation of Tramadol and to continue discussions on the consideration of Ketamine, whose use and misuse are on the rise,” he said.

Additionally, he highlighted the worrying trend of incorporating veterinary medicines, such as Xylazine, into drug mixtures, a practice that has alarmed health authorities.

“We have further witnessed the increased use of veterinary medicines such as Xylazine in drug mixtures. We call on WHO for further review and guidance on control measures,” he added.

The 68th CND serves as a key platform for international drug policy discussions, enabling member states to share insights and strategies for addressing drug-related challenges.

Kenya’s call for stronger measures against the misuse of Tramadol, Ketamine, and veterinary drugs is expected to contribute to broader discussions on safeguarding public health and reinforcing global drug control frameworks.